about
The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4.Wtip- and gadd45a-interacting protein dendrin is not crucial for the development or maintenance of the glomerular filtration barrier.Artemisinin analogue SM934 ameliorates the proteinuria and renal fibrosis in rat experimental membranous nephropathy.The role of retinoic acid receptors in the signal pathway of all-trans retinoic acid-induced differentiation in adriamycin-induced podocyte injury.Minimal-change disease in adolescents and adults: epidemiology and therapeutic response.Human apolipoprotein L1 (ApoL1) in cancer and chronic kidney disease.Podocyte Number in Children and Adults: Associations with Glomerular Size and Numbers of Other Glomerular Resident CellsUnderstanding the mechanisms of proteinuria: therapeutic implicationsThe phenotypes of podocytes and parietal epithelial cells may overlap in diabetic nephropathy.The emergence of the glomerular parietal epithelial cell.Perturbation of physiological systems by nanoparticles.Hypoacusia and chronic renal dysfunction: new etiopathogenetic prospective.The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update.Podocytes from the diagnostic and therapeutic point of view.Human podocyte depletion in association with older age and hypertension.Podocyturia: Potential applications and current limitations.New insights into glomerular parietal epithelial cell activation and its signaling pathways in glomerular diseases.
P2860
Q34105415-DE062CF9-7A14-4275-9E86-0591558CFCB0Q35077937-A2E93722-246E-4712-A4EF-AAC86D1C34B6Q35080166-6D97AC92-2FE1-43AC-ABF8-D733E748BC56Q35171746-B77C4CB0-C306-46BF-B1BB-2F67D362EF58Q35626525-B7DDF691-E3DF-4A3D-9A25-B3C3C075DADDQ35950501-A00E429B-0963-4ACA-95F5-F2FA2259306BQ36003114-5C1637FE-18A3-49BC-80BE-785856618220Q36100123-D7E50DA5-FD76-46D4-B021-E2DD15A72348Q36299942-FE335BF8-F6EA-45C9-AFCD-D7084C9C054FQ38182323-4A269B29-19C8-4289-89B4-BDB3A86FEF1EQ38197488-CA0FEEAA-E184-4E3E-8081-7A320BB25816Q38254461-D20A2FF9-C237-4E77-8208-88744E7DEAD7Q38383524-3D2DFFD2-3085-493D-AF4E-A6A1F8A29680Q39309473-53B022B6-810B-4034-9958-2B3FBB66BEF0Q40081561-55270280-5F74-40FC-BC8F-28A0C88D3985Q41659964-4A092C50-E4DA-42C2-AE90-2E1CDF66B56CQ42053344-60E65A35-71C1-4BED-A96B-A47FE8961967
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Podocyte disorders: Core Curriculum 2011
@ast
Podocyte disorders: Core Curriculum 2011
@en
Podocyte disorders: Core Curriculum 2011
@nl
type
label
Podocyte disorders: Core Curriculum 2011
@ast
Podocyte disorders: Core Curriculum 2011
@en
Podocyte disorders: Core Curriculum 2011
@nl
prefLabel
Podocyte disorders: Core Curriculum 2011
@ast
Podocyte disorders: Core Curriculum 2011
@en
Podocyte disorders: Core Curriculum 2011
@nl
P2093
P1476
Podocyte disorders: Core Curriculum 2011
@en
P2093
Behzad Najafian
J. Ashley Jefferson
Peter J. Nelson
Stuart J. Shankland
P304
P356
10.1053/J.AJKD.2011.05.032
P407
P577
2011-10-01T00:00:00Z